The PMHNP understands the benefits of gaining a good genetic history along with genetic testing (genotype) may promote which of the following patient outcomes: (Select all that apply).

A. May optimize pharmacological compliance: Understanding a patient’s genetic profile can help select medications with the highest likelihood of efficacy and tolerability, which can improve adherence and willingness to continue treatment. B. Potentially decreases debilitating side-effects: Genetic testing can identify variants in drug-metabolizing enzymes that predispose patients to adverse effects. Tailoring medications accordingly can reduce the risk of severe or intolerable side effects. C. Serves as a biomarker of pharmacological efficacy: Certain genotypes predict responsiveness to specific psychotropic medications. Using this information allows clinicians to anticipate efficacy and choose medications most likely to benefit the patient.